Dr Fabio Miyajima PhD, MSc, BDS

MRC Programme Investigator | Research Fellow Pharmacology & Therapeutics


Research Interest 1

My research interests are in the molecular epidemiology of healthcare-associated infections, dysbiosis following antimicrobial therapy, age-related conditions and translational medicine. My research focuses on the identification and validation of predictive biomarkers for variable response in patients in terms of diagnosis, prognosis, susceptibility and efficacy. My main research goals are in understanding the complex interplay of enteric infections and comorbidities, using genomics, transcriptomics, proteomics and metabolomics tools with a view on translational measures to control diseases, improve patient's management and treatment efficacy.

Research Group Membership

Research Grants

The Interactions Between Clostridium Difficile, Intestinal Microbiota and the Host Response in Hospitalised Patients.


September 2012 - March 2018

Research Collaborations

Dr. James Anson, Dr. Caroline Corless and Paul Roberts

External: Liverpool Clinical Laboratories - Royal Liverpool & Broadgreen Hospitals NHS Trust

Development and standardisation of methods for screening and classification of Clostridium difficile
Pathological screening of specimens

Prof. Brendan Wren

External: London School of Hygiene and Tropical Medicine

Multicentric MRC programme grant
Pathogenesis of bacterial infections

Dr. Trevor Lawley

External: Wellcome Trust Sanger Institute

Macro and micro evolution of epidemic bacterial strains and microbiota profiling of enteric diseases

Prof. Dyfrig Hughes

External: Centre for Economics, University of Bangor

Health-economics of Clostridium difficile infection

Prof. Tor Savidge

External: Baylor College of Medicine, Houston, Texas, USA

Metabolomics of Clostridium difficile infection
Network and mechanistic analyses